1. Home
  2. BDX

as of 03-09-2026 1:28pm EST

$164.16
$3.24
-1.93%
Stocks Health Care Medical/Dental Instruments Nasdaq

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.

Founded: 1897 Country:
United States
United States
Employees: N/A City: FRANKLIN LAKES
Market Cap: 51.5B IPO Year: 1994
Target Price: $189.60 AVG Volume (30 days): 2.7M
Analyst Decision: Buy Number of Analysts: 11
Dividend Yield:
2.51%
Dividend Payout Frequency: semi-annual
EPS: 1.34 EPS Growth: -0.68
52 Week Low/High: $162.46 - $231.82 Next Earning Date: 05-07-2026
Revenue: $21,840,000,000 Revenue Growth: 8.24%
Revenue Growth (this year): -11.04% Revenue Growth (next year): 2.53%
P/E Ratio: 124.92 Index:
Free Cash Flow: 3.9B FCF Growth: -10.39%

Stock Insider Trading Activity of Becton Dickinson and Company (BDX)

Feld Michael

EVP, Chief Revenue Officer

Sell
BDX Feb 26, 2026

Avg Cost/Share

$181.84

Shares

75

Total Value

$13,638.00

Owned After

21,308

SEC Form 4

Sell
BDX Feb 18, 2026

Avg Cost/Share

$182.61

Shares

953

Total Value

$174,027.33

Owned After

36,763

SEC Form 4

Feld Michael

EVP, CRO & Pres. Life Sciences

Sell
BDX Jan 26, 2026

Avg Cost/Share

$202.73

Shares

75

Total Value

$15,204.75

Owned After

21,308

SEC Form 4

Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Sell
BDX Jan 15, 2026

Avg Cost/Share

$207.77

Shares

1,610

Total Value

$334,005.40

Owned After

13,105

Feld Michael

EVP, CRO & Pres. Life Sciences

Sell
BDX Dec 26, 2025

Avg Cost/Share

$196.08

Shares

74

Total Value

$14,509.92

Owned After

21,308

SEC Form 4

Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Sell
BDX Dec 17, 2025

Avg Cost/Share

$196.03

Shares

629

Total Value

$123,302.87

Owned After

13,105

SEC Form 4

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2025
Q4

Q4 2025 Earnings

8-K SELL

Feb 9, 2026 · 100% conf.

AI Prediction SELL

1D

-1.40%

$204.48

5D

-2.29%

$202.64

20D

-0.88%

$205.56

Price: $207.39 Prob +5D: 0% AUC: 1.000
0001628280-26-006182

bdx-202602090000010795false00000107952026-02-092026-02-090000010795us-gaap:CommonStockMemberexch:XNYS2026-02-092026-02-090000010795bdx:Notes1.900dueDecember152026Memberexch:XNYS2026-02-092026-02-090000010795bdx:Notes1.208dueJune42026Memberexch:XNYS2026-02-092026-02-090000010795bdx:Notes1213DueFebruary122036Memberexch:XNYS2026-02-092026-02-090000010795bdx:Notes3.519DueFebruary82031Memberexch:XNYS2026-02-092026-02-090000010795bdx:Notes3.828DueJune72032Memberexch:XNYS2026-02-092026-02-09

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO

SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) February 9, 2026

BECTON, DICKINSON AND COMPANY

(Exact Name of Registrant as Specified in Its Charter)

New Jersey

(State or Other Jurisdiction of Incorporation)

001-4802 22-0760120 (Commission File Number) (IRS Employer Identification No.)

1 Becton Drive, Franklin Lakes,New Jersey 07417-1880 (Address of Principal Executive Offices) (Zip Code)

(201) 847-6800

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K Filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each ClassTrading SymbolName of each exchange on which registered

Common stock, par value $1.00BDXNew York Stock Exchange 1.900% Notes due December 15, 2026BDX26New York Stock Exchange 1.208% Notes due June 4, 2026BDX/26ANew York Stock Exchange 1.213% Notes due February 12, 2036BDX/36New York Stock Exchange 3.519% Notes due February 8, 2031BDX31New York Stock Exchange 3.828% Notes due June 7, 2032BDX32ANew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

ITEM 2.02    RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On February 9, 2026, Becton, Dickinson and Company (“BD”) issued a press release announcing its financial results for its first fiscal quarter ending December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report.

The press release furnished as Exhibit 99.1 contains certain financial measures that differ from those presented in accordance with U.S. generally accepted accounting principles (“non-GAAP measures”). Details regarding these non-GAAP measures and adjustments can be found in the schedules included in the press release furnished as Exhibit 99.1.

ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS.

Exhibit 99.1     Press release dated February 9, 2026, which is furnished pursuant to Item 2.02.

Exhibit 104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BECTON, DICKINSON AND COMPANY

(Registrant)

By:/s/ Stephanie M. Kelly Stephanie M. Kelly Chief Securities and Governance Counsel, Corporate Secretary

Date: February 9, 2026

2025
Q3

Q3 2025 Earnings

8-K

Nov 6, 2025

0001628280-25-049835

bdx-202511060000010795false00000107952025-11-062025-11-060000010795us-gaap:CommonStockMemberexch:XNYS2025-11-062025-11-060000010795bdx:Notes1.900dueDecember152026Memberexch:XNYS2025-11-062025-11-060000010795bdx:Notes1.208dueJune42026Memberexch:XNYS2025-11-062025-11-060000010795bdx:Notes1213DueFebruary122036Memberexch:XNYS2025-11-062025-11-060000010795bdx:Notes3.519DueFebruary82031Memberexch:XNYS2025-11-062025-11-060000010795bdx:Notes3.828DueJune72032Memberexch:XNYS2025-11-062025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO

SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) November 6, 2025

BECTON, DICKINSON AND COMPANY

(Exact Name of Registrant as Specified in Its Charter)

New Jersey

(State or Other Jurisdiction of Incorporation)

001-4802 22-0760120 (Commission File Number) (IRS Employer Identification No.)

1 Becton Drive, Franklin Lakes,New Jersey 07417-1880 (Address of Principal Executive Offices) (Zip Code)

(201) 847-6800

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K Filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each ClassTrading SymbolName of each exchange on which registered

Common stock, par value $1.00BDXNew York Stock Exchange 1.900% Notes due December 15, 2026BDX26New York Stock Exchange 1.208% Notes due June 4, 2026BDX/26ANew York Stock Exchange 1.213% Notes due February 12, 2036BDX/36New York Stock Exchange 3.519% Notes due February 8, 2031BDX31New York Stock Exchange 3.828% Notes due June 7, 2032BDX32ANew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

ITEM 2.02    RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On November 6, 2025, Becton, Dickinson and Company (“BD”) issued a press release announcing its financial results for its fourth fiscal quarter ending September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report.

The press release furnished as Exhibit 99.1 contains certain financial measures that differ from those presented in accordance with U.S. generally accepted accounting principles (“non-GAAP measures”). Details regarding these non-GAAP measures and adjustments can be found in the schedules included in the press release furnished as Exhibit 99.1.

ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS.

Exhibit 99.1     Press release dated November 6, 2025, which is furnished pursuant to Item 2.02.

Exhibit 104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BECTON, DICKINSON AND COMPANY

(Registrant)

By:/s/ Stephanie M. Kelly Stephanie M. Kelly Chief Securities and Governance Counsel, Corporate Secretary

Date: November 6, 2025

2025
Q3

Q3 2025 Earnings

8-K

Oct 15, 2025

0001628280-25-045106

bdx-202510090000010795false00000107952025-10-092025-10-090000010795us-gaap:CommonStockMemberexch:XNYS2025-10-092025-10-090000010795bdx:Notes1.900dueDecember152026Memberexch:XNYS2025-10-092025-10-090000010795bdx:Notes1.208dueJune42026Memberexch:XNYS2025-10-092025-10-090000010795bdx:Notes1213DueFebruary122036Memberexch:XNYS2025-10-092025-10-090000010795bdx:Notes3.519DueFebruary82031Memberexch:XNYS2025-10-092025-10-090000010795bdx:Notes3.828DueJune72032Memberexch:XNYS2025-10-092025-10-09

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO

SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) October 9, 2025

BECTON, DICKINSON AND COMPANY

(Exact Name of Registrant as Specified in Its Charter)

New Jersey

(State or Other Jurisdiction of Incorporation)

001-4802 22-0760120 (Commission File Number) (IRS Employer Identification No.)

1 Becton Drive, Franklin Lakes,New Jersey 07417-1880 (Address of Principal Executive Offices) (Zip Code)

(201) 847-6800

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K Filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each ClassTrading SymbolName of each exchange on which registered

Common stock, par value $1.00BDXNew York Stock Exchange 1.900% Notes due December 15, 2026BDX26New York Stock Exchange 1.208% Notes due June 4, 2026BDX/26ANew York Stock Exchange 1.213% Notes due February 12, 2036BDX/36New York Stock Exchange 3.519% Notes due February 8, 2031BDX31New York Stock Exchange 3.828% Notes due June 7, 2032BDX32ANew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

ITEM 2.02    RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On October 15, 2025, Becton, Dickinson and Company (the “Company”) issued a press release announcing its preliminary unaudited revenue for its fourth quarter and full fiscal year ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report.

The press release furnished as Exhibit 99.1 contains certain financial measures that differ from those presented in accordance with U.S. generally accepted accounting principles (“non-GAAP measures”). Details regarding these non-GAAP measures and adjustments can be found in the schedules included in the press release furnished as Exhibit 99.1.

The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

ITEM 5.02     DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.

On October 9, 2025, Christopher J. DelOrefice informed Becton, Dickinson and Company (the “Company” or “BD”) of his intention to resign from his position as the Company’s Executive Vice President and Chief Financial Officer effective December 5, 2025 to pursue a new professional opportunity. Mr. DelOrefice will remain in his current role with the Company until his departure. Mr. DelOrefice’s departure is not the result of any disagreement with the Company on any matter relating to its financial statements, internal control over financial reporting, operations, policies or practices.

In connection with Mr. DelOrefice’s departure from the position of Chief Financial Officer, Vitor Roque, Senior Vice President of Finance, Business Units and Corporate Financial Planning & Analysis, has been appointed by the Company’s Board of D

Latest Becton Dickinson and Company News

BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing

All BDX News

Share on Social Networks: